GlassScriptPhysician profile
Timothy Harvey Hogan
NPI 1154414837
$592.59
in general payments reported to CMS, 2019-2025
14 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.00 · 2020: $61.20 · 2021: $53.61 · 2022: $33.31 · 2023: $126 · 2024: $185 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $132.70 | 2019-2025 | Evenity, Prolia |
| Exact Sciences Corporation | $113.25 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $58.43 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $53.60 | 2024 | Voquezna |
| Axsome Therapeutics, INC. | $50.84 | 2023-2024 | Sunosi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.03 | 2024-2025 | Xifaxan |
| Abbvie INC. | $34.39 | 2022-2023 | |
| Astellas Pharma US INC | $27.02 | 2023-2024 | Veozah |
| Aimmune Therapeutics, INC. | $17.20 | 2025 | Zenpep |
| Glaxosmithkline, LLC. | $15.24 | 2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $14.71 | 2025 | Breztri |
| Novo Nordisk INC | $14.33 | 2024 | Wegovy |
| Merck Sharp & Dohme LLC | $12.83 | 2020 | |
| Allergan, INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.